tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market
CNSP
CNS Pharmaceuticals
RESEARCH TOOLSreports
Want to see CNSP full AI Analyst Report?

CNS Pharmaceuticals (CNSP) Ratios

1,096 Followers

CNS Pharmaceuticals Ratios

CNSP's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, CNSP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 1.98 1.98 3.43 0.26 2.55
Quick Ratio
 1.98 1.98 3.43 0.26 2.55
Cash Ratio
 1.76 1.76 2.56 0.09 2.04
Solvency Ratio
 -3.86 -3.86 -5.88 -3.07 -3.10
Operating Cash Flow Ratio
 -3.37 -3.37 -6.78 -2.31 -2.15
Short-Term Operating Cash Flow Coverage
 -42.03 -42.03 -52.48 -47.01 -25.75
Net Current Asset Value
$ 4.00M$ 4.00M$ 6.13M$ -4.54M$ 7.64M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.04 0.18 0.03
Debt-to-Equity Ratio
 0.07 0.07 0.05 -0.07 0.05
Debt-to-Capital Ratio
 0.07 0.07 0.05 -0.07 0.05
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.91 1.91 1.41 -0.38 1.60
Debt Service Coverage Ratio
 -46.05 -46.05 -43.36 -59.95 -36.58
Interest Coverage Ratio
 -1.05K -1.05K -924.50 -1.37K -2.13K
Debt to Market Cap
 0.07 0.14 0.14 <0.01 <0.01
Interest Debt Per Share
 0.78 0.78 10.74 0.05 0.18
Net Debt to EBITDA
 0.43 0.43 0.41 0.01 0.63
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
99.15%99.15%99.70%99.93%102.28%
Return on Assets (ROA)
-183.81%-183.81%-170.76%-1108.34%-117.02%
Return on Equity (ROE)
-164.56%-350.48%-240.55%425.33%-187.81%
Return on Capital Employed (ROCE)
-353.49%-353.49%-241.26%425.65%-183.61%
Return on Invested Capital (ROIC)
-329.54%-329.54%-229.17%456.64%-174.80%
Return on Tangible Assets
-183.81%-183.81%-170.76%-1108.34%-117.02%
Earnings Yield
-456.00%-680.96%-645.69%>-0.01%>-0.01%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 <0.01 <0.01 <0.01
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 0.00 0.00 -242.70K -514.93K -114.32K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 242.70K 514.93K 114.32K
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -31.15 -31.15 -537.26 -2.27 -4.67
Free Cash Flow Per Share
 -31.19 -31.19 -537.39 -2.27 -4.67
CapEx Per Share
 0.04 0.04 0.13 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -759.90 -759.90 -4.09K -3.62K -2.39K
Capital Expenditure Coverage Ratio
 -759.90 -759.90 -4.09K -3.62K -2.39K
Operating Cash Flow Coverage Ratio
 -42.03 -42.03 -52.48 -47.01 -25.75
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-307.00%-594.12%-743.90%>-0.01%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.21 -0.15 -0.15 -12.58K -10.66K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.75 0.51 0.37 -53.51K 20.01K
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.32 -0.17 -0.13 -16.77K -15.41K
Price-to-Operating Cash Flow Ratio
 -0.25 -0.17 -0.13 -16.77K -15.42K
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 226.95 -5.28
Price-to-Fair Value
 0.75 0.51 0.37 -53.51K 20.01K
Enterprise Value Multiple
 0.16 0.29 0.26 -12.57K -10.67K
Enterprise Value
 -2.37M -4.54M -3.83M 237.17B 162.75B
EV to EBITDA
 0.15 0.29 0.26 -12.57K -10.67K
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 0.17 0.33 0.22 -16.77K -15.41K
EV to Operating Cash Flow
 0.17 0.33 0.22 -16.77K -15.41K
Tangible Book Value Per Share
 10.20 10.20 193.91 -0.71 3.60
Shareholders’ Equity Per Share
 10.20 10.20 193.91 -0.71 3.60
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -35.75 -35.75 -466.45 -3.03 -6.76
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.87 0.87 1.15 0.75 0.69
Currency in USD